Isosulfan blue
Isosulfan Blue is a prescription drug manufactured by Eugia US LLC, available as a subcutaneous injection solution with 50 mg in 5 mL vials. It was approved under ANDA206831 and marketed starting February 2016, but is now discontinued. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Isosulfan Blue is a prescription drug manufactured by Eugia US LLC, available as a subcutaneous injection solution with 50 mg in 5 mL vials. It was approved under ANDA206831 and marketed starting February 2016, but is now discontinued. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Isosulfan blue", "mediaType": "text/html", "description": " Access the FDA dataset for Isosulfan blue — ANDA 213130 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213130" } ] |
| identifier | ANDA213130 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-information", "fda", "medications", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Isosulfan blue |
